Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2017-01
Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity.
Abstract
Background and purpose
To evaluate outcomes and toxicity in patients treated with hyperfractionated pelvic reirradiation for recurrent rectal cancer.
Materials and methods
102 patients with recurrent rectal adenocarcinoma were treated with pelvic reirradiation with a hyperfractionated accelerated approach, consisting of 1.5Gy twice daily fractions to a total dose of 30-45Gy (median 39Gy), with the most common total dose 39Gy (n=90, 88%). The median dose of prior pelvic radiation therapy (RT) was 50.4Gy (range: 25-63Gy).
Results
The median follow-up was 40months for living patients (range, 3-150months). The 3-year freedom from local progression (FFLP) rate was 40% and the 3-year overall survival (OS) rate was 39%. Treatment with surgery was significantly associated with improved FFLP and OS, with 3-year FFLP rate of 49% vs. 30% (P=0.013), and 3-year OS rate of 62% vs. 20% (P<0.0001), compared to those without surgery. The actuarial 3-year rate of grade 3-4 late toxicity was 34%; patients who underwent surgery had a significantly higher rate of grade 3-4 late toxicity compared to those without surgery (54% vs. 16%, P=0.001).
Conclusions
This large, retrospective, single-institution study shows that hyperfractionated accelerated reirradiation was well tolerated. The rate of FFLP was promising, given that the study comprised heavily pre-treated patients with recurrences. Rates of FFLP and OS were particularly impressive in patients who underwent both reirradiation and surgery.
Related Questions
Would you offer pelvic re-irradiation in the setting of locally recurrent anal cancer in the presacral region?
Re-irradiation is always tricky. I don't want to miss a chance to help someone, and I really don't want to hurt someone. With re-irradiation, the devil is in the details. If it is small, in a spot where symptomatic toxicity is less likely, and a long period of time has passed since the original chem...
Would you alter radiation recommendations for a patient with locally advanced rectal cancer and a history of abdominopelvic lymphoma radiation 40 years ago?
In the case of more recent RT, I would get the records in order to inform treatment recommendations. However, records are typically impossible to get in this situation. We have several options here. The first is the avoidance of radiation, as was recently reported in the PROSPECT study. (Schrag et a...
Do you use the re-radiation schedule 39Gy in 26 fx BID for a rectal patient who initially received 25 Gy in 5 fractions and then has pelvic recurrence?
We have retreated rectal cancer patients with pelvic reRT (using protons) with doses as high as 39-45 Gy BID after both conventional fractionation and 25 Gy/5fx. In patients with prolonged interval since the original RT, no other sites of disease, good ECOG, and no good systemic/surgical options, th...
Would you recommend repeat radiation therapy for a painful perineal recurrence in a patient who failed definitive CRT, and recurred again after salvage abdominoperineal resection (APR)?
I think repeat radiation therapy is certainly an option that can be offered to this patient, especially if the interval between treatments is long. MD Anderson reported on a series of 10 patients with anal SCCs treated with reirradiation after definitive CRT (https://www.ncbi.nlm.nih.gov/pubmed/2775...